These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38288547)
21. Deciphering the role of TRIB1 in regulatory T-cells. Danger R; Dugast E; Braza F; Conchon S; Brouard S Biochem Soc Trans; 2015 Oct; 43(5):1075-8. PubMed ID: 26517926 [TBL] [Abstract][Full Text] [Related]
22. A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function. Loo CS; Gatchalian J; Liang Y; Leblanc M; Xie M; Ho J; Venkatraghavan B; Hargreaves DC; Zheng Y Immunity; 2020 Jul; 53(1):143-157.e8. PubMed ID: 32640256 [TBL] [Abstract][Full Text] [Related]
23. Regulatory T cells in autoimmune kidney diseases and transplantation. Mikami N; Sakaguchi S Nat Rev Nephrol; 2023 Sep; 19(9):544-557. PubMed ID: 37400628 [TBL] [Abstract][Full Text] [Related]
25. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application. Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732 [TBL] [Abstract][Full Text] [Related]
26. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses. Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345 [TBL] [Abstract][Full Text] [Related]
27. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562 [TBL] [Abstract][Full Text] [Related]
28. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780 [TBL] [Abstract][Full Text] [Related]
29. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol. Schmidt A; Éliás S; Joshi RN; Tegnér J J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341 [TBL] [Abstract][Full Text] [Related]
31. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665 [TBL] [Abstract][Full Text] [Related]
32. Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications. Iizuka-Koga M; Nakatsukasa H; Ito M; Akanuma T; Lu Q; Yoshimura A J Autoimmun; 2017 Sep; 83():113-121. PubMed ID: 28709726 [TBL] [Abstract][Full Text] [Related]
33. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells. Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202 [TBL] [Abstract][Full Text] [Related]
34. Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules. Haddadi MH; Negahdari B; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Dabiri H; Baharvand H Clin Exp Immunol; 2020 Aug; 201(2):205-221. PubMed ID: 32403163 [TBL] [Abstract][Full Text] [Related]
35. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells. Bhaumik S; Mickael ME; Moran M; Spell M; Basu R J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Treg Functions by the Ubiquitin Pathway. Montauti E; Fang D Adv Exp Med Biol; 2021; 1278():47-62. PubMed ID: 33523442 [TBL] [Abstract][Full Text] [Related]
37. Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3. Schmidt A; Marabita F; Kiani NA; Gross CC; Johansson HJ; Éliás S; Rautio S; Eriksson M; Fernandes SJ; Silberberg G; Ullah U; Bhatia U; Lähdesmäki H; Lehtiö J; Gomez-Cabrero D; Wiendl H; Lahesmaa R; Tegnér J BMC Biol; 2018 May; 16(1):47. PubMed ID: 29730990 [TBL] [Abstract][Full Text] [Related]
38. [Effects of Foxp3 knockdown on the functions of human regulatory T cells]. Sun L; Yi SN; Chen L Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(30):2124-8. PubMed ID: 22093989 [TBL] [Abstract][Full Text] [Related]